[Retracted] Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma

<div>Relationship of miR-655 with the prognosis of patients. (a) OS of the high expression group was higher than that of the low expression group in 2 years. (b) PFS of the high expression group was higher than that of the low expression group in 2 years.</div>

Emergency Medicine International

fig4

Figure 4

Figure 4: [Retracted] Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma 

Figure 4 | [Retracted] Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma 